SAN DIEGO and SUZHOU, China, May 22, 2024 (GLOBE NEWSWIRE) -- Adagene Inc. ("Adagene") (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced its participation in multiple investor conferences in June 2024.
Adagene's Chairman, Chief Executive Officer and President of R&D, Peter Luo, Ph.D., will provide a company update, including progress on the masked, anti-CTLA-4 SAFEbody ADG126. Company management will also host investor meetings.
Jefferies Global Healthcare Conference 2024
Date: Wednesday, June 5
Time: 4:30-4:55 PM (Eastern Time)
Location: New York City
Goldman Sachs 45th Annual Global Healthcare Conference
Date: Thursday, June 13
Time: 10:00-10:35 AM (Eastern Time)
Location: Miami
HC Wainwright 2nd Annual Immune Cell Engager Virtual Conference
Date: Tuesday, June 25
Time: TBD for presentation
Location: Virtual
A live webcast of the presentations will also be accessible in the Investors section of the company's website. A webcast replay will be available for at least 30 days.